This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
This study is the first to provide compelling evidence of a causal link between EBV and MS.
New data on DMT use in progressive MS presented at CMSC 2021 — including results from the ACAPELLA and EXPAND trials, and the novel agent ATA188...
Key updates from CMSC 2021 on prevalent multiple sclerosis comorbidities including prevalence of hypertension, elevated BMI, depression, and...
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or...
Because there currently is no established DMT selection algorithm, specialty pharmacists can assist in medication education and management.